How Traditional Chinese Medicine Treats Atopic Dermatitis

Atopic dermatitis (AD), a chronic, relapsing inflammatory skin disorder characterized by intense pruritus, eczematous lesions, and skin barrier dysfunction, presents a significant clinical challenge—particularly in patients with moderate-to-severe disease or those who experience suboptimal responses to conventional therapies. While modern dermatology relies heavily on topical corticosteroids, calcineurin inhibitors, and increasingly, biologic agents such as dupilumab and tralokinumab, growing interest has emerged in integrative approaches—including Traditional Chinese Medicine (TCM)—as adjunctive or alternative strategies.

Within the TCM framework, atopic dermatitis is not viewed as an isolated skin condition but rather as a manifestation of systemic imbalance. Practitioners commonly categorize AD under “shi chuang” (damp sores) or “feng re zhen” (wind-heat rash), with patterns varying by disease stage and individual constitution. Acute flares are frequently attributed to wind-heat or damp-heat accumulation, often involving the Lung and Spleen meridians; chronic, lichenified phases may reflect blood deficiency with wind-dryness or yin deficiency with internal heat. Diagnosis hinges on comprehensive assessment—not only of skin morphology and distribution but also of tongue appearance (e.g., red tongue with yellow greasy coating in damp-heat), pulse quality (slippery or rapid in excess patterns; thready and weak in deficiency states), and constitutional symptoms such as fatigue, digestive irregularity, or emotional stress.

TCM management emphasizes pattern differentiation and multimodal intervention. Herbal therapy forms the cornerstone: internally administered formulas like Xiao Feng San (Eliminate Wind Powder) for wind-heat dominance, or Si Wu Xiao Feng Yin (Four Substances Wind-Dispelling Decoction) for blood deficiency with wind-dryness, are tailored to the patient’s evolving presentation. Topical applications—including herbal washes, liniments, or ointments containing ingredients such as Sophora flavescens, Dictamnus dasycarpus, or Glycyrrhiza uralensis—are used to clear heat, resolve dampness, and alleviate pruritus while minimizing steroid-induced skin atrophy. Acupuncture—targeting points such as LI11 (Quchi), SP10 (Xuehai), and BL13 (Feishu)—may modulate neuroimmune pathways, reduce itch perception, and support regulatory T-cell function, though mechanistic evidence remains preliminary.

Importantly, TCM treatment is inherently personalized and dynamic: formulas are modified weekly or biweekly based on symptom evolution and treatment response. Lifestyle and dietary guidance—such as avoiding known food triggers (e.g., shellfish, dairy, or spicy foods in damp-heat patterns) and emphasizing spleen-strengthening foods like cooked oats, pumpkin, and adzuki beans—is considered integral to long-term control. Rigorous clinical trials remain limited, and existing evidence—while promising in small-scale studies—lacks the methodological robustness required for broad guideline endorsement. Therefore, TCM should be pursued collaboratively with board-certified dermatologists, particularly given risks of herb–drug interactions (e.g., with immunosuppressants) and potential adulteration of unregulated herbal products.

In summary, TCM offers a holistic, individualized paradigm for managing atopic dermatitis—one that addresses cutaneous inflammation alongside underlying constitutional and environmental contributors. When integrated thoughtfully and safely into multidisciplinary care, it may enhance symptom control, reduce reliance on high-potency topical steroids, and improve quality of life for select patients. Ongoing research into standardized herbal formulations and rigorous pragmatic trials will be essential to define its precise role in contemporary AD management.